Time of HIV Diagnosis and Engagement in Prenatal Care Impact Virologic Outcomes of Pregnant Women with HIV - Wikidata - wikimedia - TriplyDB

Time of HIV Diagnosis and Engagement in Prenatal Care Impact Virologic Outcomes of Pregnant Women with HIV

Time of HIV Diagnosis and Engagement in Prenatal Care Impact Virologic Outcomes of Pregnant Women with HIV

http://www.wikidata.org/entity/Q28546081

about

Pre-conception counselling for key cardiovascular conditions in Africa: optimising pregnancy outcomes Evolving treatment implementation among HIV-infected pregnant women and their partners: results from a national surveillance study in Italy, 2001-2015 Mode of Delivery among HIV-Infected Pregnant Women in Philadelphia, 2005-2013.Loss to Follow-Up After Pregnancy Among Sub-Saharan Africa-Born Women Living With Human Immunodeficiency Virus in England, Wales and Northern Ireland: Results From a Large National Cohort HIV-1 infection and pregnancy in young women in Brazil: socioeconomic and drug resistance profiles in a cross-sectional study.Factors Associated with PMTCT Cascade Completion in Four African Countries.Assessing the Impact of Perinatal HIV Case Management on Outcomes Along the HIV Care Continuum for Pregnant and Postpartum Women Living With HIV, Philadelphia 2005-2013.Pregnancy and linkage to care among women diagnosed with HIV infection in 61 CDC-funded health departments in the United States, 2013.Postpartum Engagement in HIV Care: An Important Predictor of Long-term Retention in Care and Viral Suppression.Unplanned pregnancies and contraceptive use among HIV- positive women in care.Evaluating outcomes of mother-infant pairs using dolutegravir for HIV treatment during pregnancy

P2860

Q26746827-BF744D67-B15F-48C7-9489-768379F9383A Q33718592-827F892F-AA5C-45A2-A402-225A4654B74D Q35866598-0E861825-88C1-4439-B70E-94E0FBE062AE Q36826245-CD7B8672-11FE-4613-AA45-676A50134874 Q37100859-BD0305DB-0171-4789-8F2F-44E0EB00BF9C Q37411580-52246BDC-71E9-45C8-AE76-23CB3DCD9637 Q38973008-0E43DA73-DC59-4F7F-BACB-CD4139E4038B Q38993301-7B31E0F8-E94A-485A-87CB-2F4081529EEA Q41057438-0029B58A-9BA5-4470-8E3F-B978D1B1C98C Q54208723-B5B1089C-5815-4028-B7F4-0A8E10393FC9 Q58767934-40D5D490-F30A-409C-8403-9A8879631496

P2860

Time of HIV Diagnosis and Engagement in Prenatal Care Impact Virologic Outcomes of Pregnant Women with HIV

http://www.wikidata.org/entity/Q28546081

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Time of HIV Diagnosis and Enga ...... mes of Pregnant Women with HIV

@ast

Time of HIV Diagnosis and Enga ...... mes of Pregnant Women with HIV

@en

Time of HIV Diagnosis and Enga ...... mes of Pregnant Women with HIV

@nl

type

label

Time of HIV Diagnosis and Enga ...... mes of Pregnant Women with HIV

@ast

Time of HIV Diagnosis and Enga ...... mes of Pregnant Women with HIV

@en

Time of HIV Diagnosis and Enga ...... mes of Pregnant Women with HIV

@nl

prefLabel

Time of HIV Diagnosis and Enga ...... mes of Pregnant Women with HIV

@ast

Time of HIV Diagnosis and Enga ...... mes of Pregnant Women with HIV

@en

Time of HIV Diagnosis and Enga ...... mes of Pregnant Women with HIV

@nl

P1433

Q28546081-734DF263-B2C6-4351-9C51-50657CCEE6CB

P1476

Q28546081-18CDE372-65F9-4491-AD75-3FA2A748CF54

P2093

Q28546081-18B05CAD-35BD-47C7-8AFE-1E2FAF9E1F15

Q28546081-24324F08-9E80-482A-B216-555B098CEC0A

Q28546081-6B3B1BC9-2960-4DCA-94FC-98665F0552AF

Q28546081-A252ED56-275A-44DF-B897-F3B232494ADF

Q28546081-A8190224-8681-49D3-A50A-8A6C808AD9C7

Q28546081-D081300A-D615-439A-891B-D3FBFCA2A0DE

P2860

Q28546081-1377BFC9-5403-4963-9DFD-00CBC572A4DC

Q28546081-13FB9DAF-B0B0-4D31-8DD7-FE38B31721A0

Q28546081-145B5EFB-ED93-4982-B76D-5C0BEDC19D64

Q28546081-15D4EA83-706D-4E8C-9586-740E1EFA5B46

Q28546081-1CBD4EFD-DEE2-44F6-AB2B-00EEBDEE2270

Q28546081-292A6ED8-EFF0-4602-935D-B15CE3F8BB71

Q28546081-2BC9B7AF-052C-441C-8AF8-AFD17494B0C1

Q28546081-2F733ECF-9766-4D0D-971F-D4FD136E2F96

Q28546081-3931F017-34EB-4FF0-8852-601CBEF768B8

Q28546081-3AB0E28B-435B-4C18-94D2-97E29344B54B

P304

Q28546081-3368D89F-C7F2-417D-A1AB-7C480B57B739

P31

Q28546081-85E83793-6157-4002-B390-DF585D479BD6

P3181

Q28546081-D71E5FB2-1E3E-42DB-ABA4-07387F8F096C

P356

Q28546081-99D030E1-C7B8-42A4-B767-BDCC77B83D79

P407

Q28546081-6F804744-2D93-451A-B390-F3947915448F

P433

Q28546081-1BA680D7-3A0C-46D6-9016-3BE167C0E339

P478

Q28546081-9E30D9B4-64DD-4B30-88EC-6E3646432598

P577

Q28546081-CA6F6427-EB0D-4C78-8E06-2C6359F54A6F

P5875

Q28546081-624370D5-21B1-4448-8649-849D6F0F4613

P698

Q28546081-4F58EC5A-161F-4CB0-9043-9FCC565303B9

P921

Q28546081-4714DED4-56CD-41BC-92CA-A568B03C3505

Q28546081-8A04C99C-28AF-45B0-8393-3D7192B31F07

Q28546081-ACE59891-8169-4CCF-832E-F2081BBA1E9D

P932

Q28546081-CAECFF70-5A74-409A-BE47-564979BEAF10

P3181

P356

JOURNAL.PONE.0132262

P1433

P1476

Time of HIV Diagnosis and Enga ...... mes of Pregnant Women with HIV

@en

P2093

Ana Diez Roux

http://www.w3.org/2001/XMLSchema#string

Baligh R Yehia

http://www.w3.org/2001/XMLSchema#string

Dana R Thompson

http://www.w3.org/2001/XMLSchema#string

Florence M Momplaisir

http://www.w3.org/2001/XMLSchema#string

Kathleen A Brady

http://www.w3.org/2001/XMLSchema#string

Thomas Fekete

http://www.w3.org/2001/XMLSchema#string

P2860

Adherence to combination prophylaxis for prevention of mother-to-child-transmission of HIV in Tanzania

Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice.

Risk factors for detectable HIV-1 RNA at delivery among women receiving highly active antiretroviral therapy in the women and infants transmission study.

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.

Apoptosis in cord blood T lymphocytes from infants of human immunodeficiency virus-infected mothers

Barriers to accessing highly active antiretroviral therapy by HIV-positive women attending an antenatal clinic in a regional hospital in western Uganda.

Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants?

Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011.

Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.

A randomized, controlled trial of financial incentives for smoking cessation.

P304

e0132262

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1957444

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0132262

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279731958

http://www.w3.org/2001/XMLSchema#string

P698

26132142

http://www.w3.org/2001/XMLSchema#string

P921

P932

4489492

http://www.w3.org/2001/XMLSchema#string